MicroMatrices provides mechanism-based risk assessment research services to the pharmaceutical, chemical, and agrochemical industries. Home of SpheroMatrices, a spheroid tissue microarray platform (patent pending) combining spheroid tissue microarray manufacture and automated image analysis. We specialise in high resolution cell type-specific analysis to characterise toxicological responses in different cell types in the tissue. This facilitates the design of in vitro models for screening and assessment of the relevance of mechanisms identified in vivo to man. A list of services currently on offer includes, but is not limited to the following: • Archival FFPE Studies for Hypothesis Generation, Mode of Action Understanding, Threshold Based Risk Assessment and Non Human Relevance • Laser Dissection Targeted (LDT) Microarray & Pathways Analysis • RNAscope in situ Hybridisation (ISH)/immunostaining (IHC) and Image Analysis (ISH & IHC analysis) and colocalisation • Zebrafish Array Analysis • Biomarker Discovery/Characterisation • Drug Target Tissue Mapping • Product Rescue/Repositioning MicroMatrices projects are scalable, efficient and flexible.